Electrophysiology Market 2024 to 2034: North America Leads in Market Share and CAGR | Future Market Insights, Inc.

December 17, 2024 5:30 AM

The global Electrophysiology Market is expected to experience robust growth from 2024 to 2034, driven by advancements in medical technology, rising prevalence of cardiovascular diseases, and increased demand for minimally invasive procedures. The market size in 2024 is projected to be USD 4,350.7 billion and is expected to reach USD 9,078.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.6%. This growth is primarily fueled...

Read more

Ondine Commencing US Phase 3 Clinical Trial

December 17, 2024 2:00 AM

Ondine Biomedical Inc. (LON:OBI), a Canadian life sciences company pioneering light-activated antimicrobial treatments, announces the imminent start of the LANTERN Phase 3 clinical trial of its novel nasal photodisinfection technology, branded as Steriwave® outside the US. The U.S. Food and Drug Administration (FDA) has raised no objections to starting the study during its statutory 30-day review period of the Company's Investigational New Drug...

Read more

Basma Aligners Named 2024's Highest-Rated Dental Aligner Company on Trustpilot With 4.8 Stars and 556 Reviews

December 17, 2024 1:00 AM

LONDON, UK / ACCESSWIRE / December 17, 2024 /Transforming Smiles with Precision and CareThis year marked significant growth for Basma, fueled by its patient-first approach and exclusive partnerships with reputable dental clinics across the GCC. Combining advanced technology, affordability, and personalized care, Basma has delivered thousands of successful smile transformations. Patients have consistently highlighted the ease, professionalism,...

Read more

Black Book Research Announces Complimentary Access to the 2025 Global Healthcare IT Resource Directory and Adoption Report

December 16, 2024 3:30 PM

Black Book Research announces the release of the 2025 Edition of The Black Book of Global Healthcare IT, a 540-page data-driven resource directory and analytical report offering a compelling and unparalleled exploration of global healthcare IT adoption. This comprehensive study delivers advanced insights into Electronic Health Records (EHR) adoption, population health tools, cybersecurity systems, and private-sector revenue cycle management...

Read more

Cloud DX Completes First Stage of Restructuring Process

December 16, 2024 2:15 PM

Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) today reports the sale of its wholly owned subsidiary Cloud Diagnostics Canada ULC (the "Company") to 1493907 B.C. Ltd (the "Purchaser").The transaction (the "Transaction") was concluded in connection with the Notice of Intention to Make a Proposal proceeding (the "NOI") announced on June 6, 2024. and was completed in accordance with the terms of a Subscription Agreement (the "Subscription...

Read more

Black Book Research Releases 2025 Global HIT Study: Client Ratings of 175 EHR Vendors Across 110 Countries

December 16, 2024 11:45 AM

Black Book Research has released its highly anticipated 2025 Global Healthcare Information Technology Study, offering an unprecedented evaluation of 175 multinational, regional, and local EHR vendors across 110 countries. Drawing from eleven months of surveys and over 13,700 validated user insights, this study provides a rigorous analysis of vendor performance against 18 critical performance indicators, including usability, interoperability,...

Read more

Managing Medicare Advantage Plan Challenges with Your Hospital’s Swing Bed Program

December 16, 2024 11:00 AM

Swing beds can be an important tool for your critical access hospital, and they can be very beneficial for patients and their families as well. In this article, we'll go over the common challenges hospitals face with a swing bed program and Medicare Advantage plans and how to combat them.Prior AuthorizationIn 2022, the United States Department of Health and Human Services' Office of Inspector General filed a report saying that 15 of the largest...

Read more

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

December 16, 2024 10:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its fourth quarter and fiscal year 2024 financial results after the market close on Tuesday, December 17, 2024.The Company will host a conference call for the investment community to coincide with an update on its GMP manufacturing facility build-out on Thursday, January...

Read more

Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM)

December 16, 2024 9:00 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced that it received approval from U.S. Food and Drug Administration (FDA) of the proprietary name, Xyngari (pronounced zin-gar-ee) (formerly DMT310), for its Phase 3 clinical drug candidate in acne. The proprietary name, Xyngari, is...

Read more

Avenir Wellness Solutions Announces Global Settlement with Ionic Ventures, Eliminating Convertible Debt

December 16, 2024 9:00 AM

Avenir Wellness Solutions, Inc. ("Avenir" or the "Company") (OTCQB:AVRW), a proprietary broad platform technology beauty and wellness company, today announced that it has reached a global settlement with its current debt holder Ionic Ventures LLC ("Ionic") to resolve all disputes between the parties.In connection with the settlement, a portion of the outstanding convertible notes with an aggregate carrying value of $8.7 million as of September...

Read more

Portland Nurse Brian Scherner Featured in Online Interview on Compassionate Care and Community Health

December 16, 2024 8:45 AM

Brian Scherner, a respected nurse manager and advocate for holistic wellness, is the subject of a newly released in-depth interview. This feature, now available online, provides a profound look into the career, philosophy, and community impact of one of Portland's most dedicated healthcare professionals.In the interview, Brian Scherner shares insights from his extensive experience in both critical and community health nursing. He discusses his...

Read more

Hoggan Scientific, LLC, Receives ISO 13485:2016 Recertification for Medical Device Quality Management System

December 16, 2024 7:00 AM

Hoggan Scientific, LLC, a globally recognized leader in the design and manufacture of medical devices, is proud to announce that it has successfully received recertification for ISO 13485:2016, the international standard for Medical Device Quality Management Systems (QMS).ISO 13485 is a stringent, internationally recognized standard that sets the requirements for quality management systems in the medical device industry. To achieve this...

Read more

Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial

December 16, 2024 1:20 AM

Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU PatientsResults Expected to Promote Awareness and Adoption of PKU GOLIKE ®GENEVA, SWITZERLAND / ACCESSWIRE / December 16, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF )(OTCQB:RLFTF )(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today...

Read more

Central Florida Foot & Ankle Institute Announces Strategic Partnership With Dr. Kevin Tootle, DPM, FACFAS

December 14, 2024 9:00 AM

Central Florida Foot & Ankle Institute (CFFAI) is proud to announce a strategic partnership with Dr. Kevin Tootle, DPM, FACFAS, a distinguished board-certified podiatric surgeon and the founder of Innovative Foot & Ankle in Mount Dora. This partnership exemplifies CFFAI's commitment to providing unparalleled foot and ankle care across Central Florida.Dr. Tootle will be accepting patients at the CFFAI Lake Mary Clinic two days per week, where he...

Read more

Quantum Biopharma Announces Closing of First Tranche

December 13, 2024 7:00 PM

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce that it has closed an initial tranche ("First Tranche") of the offering announced on December 5, 2024 (the "December 5 NR") and has issued 500 Debenture Units (as defined in the December 5 NR) for $500,000.The Company will use the proceeds from the First Tranche for the ongoing development of the Company's business model and...

Read more

Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations

December 13, 2024 5:25 PM

Company to Maintain SIX Swiss Exchange Listing, U.S. ADR Program, and U.S. OTCQB QuotationGENEVA, SWITZERLAND / ACCESSWIRE / December 13, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that it intends to file a Form 15F with the United States...

Read more

Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health's Crofelemer

December 13, 2024 10:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / December 13, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Ladenburg Thalmann is hosting a Scientific Showcase webinar on Wednesday, December 18, 2024 from 11:00 a.m. to 12:00 p.m. EST about clinical development efforts for crofelemer, Jaguar's novel plant-based anti-diarrheal prescription drug, for the ultrarare congenital diarrheal disorder MVID and the rare disease SBS-IF. To register...

Read more

IAVI and IPD Sign Agreement Formalizing Collaboration to Advance Vaccine Development, Manufacturing, and Access in Africa

December 13, 2024 9:45 AM

IAVI, a nonprofit scientific research organization dedicated to addressing urgent global health challenges including HIV, tuberculosis, and emerging infectious diseases (EIDs), and the Institut Pasteur de Dakar (IPD), a non-profit foundation focused on equitable, sustainable, and affordable access to health in Senegal, Africa, and worldwide, have signed an agreement to formally collaborate for vaccine development, manufacturing, and access in...

Read more

How Popular Weight Loss Drugs Are Reshaping Holiday Feasts

December 13, 2024 9:00 AM

VALLEY VIEW, OH / ACCESSWIRE / December 13, 2024 / As we approach the 2024 holiday season, a new trend is emerging at dinner tables across America: more leftovers. The culprit? The rising popularity of GLP-1 weight loss treatments like Ozempic, Wegovy, and Zepbound. These medications, initially developed for diabetes management, have become a game-changer in the battle against obesity. But what does this mean for our cherished holiday...

Read more

FlexCare Clinicians Donate Portable Video Game Stations to Dell Children's Medical Center

December 13, 2024 9:00 AM

FlexCare, a nationwide leader in travel nursing, allied health, and therapy talent management solutions for top healthcare facilities throughout the U.S., is delighted to announce our clinicians' donation of portable video game kiosks to Dell Children's Medical Center in Austin, Texas. Made possible by the generosity of FlexCare's clinicians, this initiative aims to bring comfort and fun to pediatric patients, allowing them to embrace the...

Read more